Life Sciences

Accelerating the speed of innovation for patients

Making the Promise of Smarter Health a Reality

Improving health is the challenge of our era. No other facet of human existence has been so rich with science, technology and investment, yet so strained by complexity, convention and misinformation. It is only in the world of health that we can read about the second case of an apparent HIV cure[1] right alongside a […]

Continue reading

Telehealth emerges as critical weapon for public health officials combating the opioid epidemic

This past October, the U.S. passed a package of bills focused on confronting the nation’s opioid epidemic. Collectively known as the SUPPORT for Patients and Communities Act[1], the legislation contains a number of legal and regulatory tweaks designed to make addiction treatment more accessible. Among them is a new focus on telehealth, which will make […]

Continue reading

Success story: The Aurum Institute

The Aurum Institute needed to integrate clinical data from cross-border research sites located in several sub-Saharan African countries, each run by data managers who speak different languages and possess varied levels of experience with electronic data capture.

Continue reading

“Connected health” designed for health

Over the years, the life sciences industry has been investing in capturing and analyzing patient health information. Specifically, companies have been creating digital health applications with the goal of improving treatment and care.

Continue reading

Discover “Discovery”

I have worked with various flavors of Watson in the last 4 years, and it has taught me a lot about the need to understand bias, both in data and the interpretation of it.  In the spirit of transparency, I will be honest about my own bias – my favorite Watson Health product is Watson […]

Continue reading

SmartAnalyst Inc. used IBM Explorys clinical data to improve how a company markets its medications

SmartAnalyst and the IBM® Watson Health™ team used the IBM Explorys® data set to study the journey of more than 6,500 real-life psoriasis patients. As a result, SmartAnalyst’s customer, a pharmaceutical company, is changing the way it communicates with patients and doctors.

Continue reading

Palliative care is “values-based care”

Value-based care is generally defined as higher quality at lower cost. Values-based care aims to achieve those same goals, but through a process that considers and applies the values of your organization, your providers and your patients.

Continue reading

Generating insights with confidence – agile advanced analytics on longitudinal health records

This webinar replay reviews how the IBM Global Business Services (GBS) team generated actionable insights by applying machine learning on integrated EHRs (IBM Explorys clinical data set) and has thus helped life science companies tailor their business strategies and achieve research breakthroughs.

Continue reading

IBM Explorys offerings for life sciences: cohort analysis

Near-real time data access provides integrated views of the patient journey and clinical practice, enabling life sciences organizations to gain deep insights.

Continue reading

Watson for Drug Discovery identifies proteins associated with cardiovascular disease

Heart attack and stroke are 2 of the top 10 causes of death worldwide. Identifying the proteins involved in each of them is the beginning of a journey to understanding how these diseases develop. In a novel experiment presented at the American Heart Association Scientific Sessions on November 12, 2017, and published in a supplement […]

Continue reading

Three principles for bringing augmented intelligence to life sciences

In today’s healthcare system, we are not getting the value for the costs we are spending. It’s a complex issue with an equally complex set of potential solutions. But as the industry shifts to value-based care, we’ve reached a tipping point.

Continue reading

IBM and Pfizer to accelerate immuno-oncology research with Watson for Drug Discovery

Watson Health and Pfizer Inc. today announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer’s research in immuno-oncology, an approach to cancer treatment that uses the body’s immune system to help fight cancer.

Continue reading